Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Vladimir V ShuvaevVladimir R Muzykantov

Abstract

Inflammatory mediators binding to Toll-Like receptors (TLR) induce an influx of superoxide anion in the ensuing endosomes. In endothelial cells, endosomal surplus of superoxide causes pro-inflammatory activation and TLR4 agonists act preferentially via caveolae-derived endosomes. To test the hypothesis that SOD delivery to caveolae may specifically inhibit this pathological pathway, we conjugated SOD with antibodies (Ab/SOD, size ~10nm) to plasmalemmal vesicle-associated protein (Plvap) that is specifically localized to endothelial caveolae in vivo and compared its effects to non-caveolar target CD31/PECAM-1. Plvap Ab/SOD bound to endothelial cells in culture with much lower efficacy than CD31 Ab/SOD, yet blocked the effects of LPS signaling with higher efficiency than CD31 Ab/SOD. Disruption of cholesterol-rich membrane domains by filipin inhibits Plvap Ab/SOD endocytosis and LPS signaling, implicating the caveolae-dependent pathway(s) in both processes. Both Ab/SOD conjugates targeted to Plvap and CD31 accumulated in the lungs after IV injection in mice, but the former more profoundly inhibited LPS-induced pulmonary inflammation and elevation of plasma level of interferon-beta and -gamma and interleukin-27. Taken together, th...Continue Reading

References

May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·V R MuzykantovA B Fisher
Nov 5, 1997·The Journal of Biological Chemistry·C TiruppathiA B Malik
Jun 15, 1999·The Journal of Cell Biology·R V StanG E Palade
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·R V StanG E Palade
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Deirdre P McIntoshJan E Schnitzer
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Arnaud ScherpereelVladimir R Muzykantov
Jun 1, 1968·The Journal of Cell Biology·G E Palade, R R Bruns
Mar 18, 2003·Journal of Cell Science·Silvia MuroMichael Koval
Oct 22, 2003·The Journal of Experimental Medicine·Mathias W HornefStaffan Normark
Dec 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Harshad S SakhalkarDouglas J Goetz
May 25, 2004·Molecular Biology of the Cell·Radu V StanIngrid R Niesman
Oct 11, 2005·Biochimica Et Biophysica Acta·Radu V Stan
Nov 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gang ZhengJerry D Glickson
Dec 24, 2005·Physiological Reviews·Dolly Mehta, Asrar B Malik
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sean GarreanAsrar B Malik
Aug 3, 2007·Advanced Drug Delivery Reviews·Maria Teresa Tarragó-Trani, Brian Storrie
Sep 26, 2007·Nature Reviews. Immunology·Jordan S Pober, William C Sessa
Aug 19, 2008·Antioxidants & Redox Signaling·Shane R ThomasGrant R Drummond
Nov 13, 2008·Antioxidants & Redox Signaling·Masuko Ushio-Fukai
Aug 21, 2009·The Journal of Pharmacology and Experimental Therapeutics·Vladimir V ShuvaevVladimir R Muzykantov
Dec 2, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Kai NowakSergei M Danilov
Jan 1, 2010·Nature Reviews. Drug Discovery·Lawrence RajendranKai Simons
Mar 23, 2010·The American Journal of Pathology·Muhammad K MirzaYou-Yang Zhao
May 22, 2010·Seminars in Thrombosis and Hemostasis·Dan Tse, Radu V Stan
Sep 30, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Vladimir V ShuvaevVladimir R Muzykantov
Feb 26, 2011·Current Pharmaceutical Design·Hongmei LiCraig L Duvall
Apr 5, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vladimir V Shuvaev, Vladimir R Muzykantov
Aug 31, 2011·Journal of Toxicology·Zacharias E Suntres
Apr 7, 2012·Biochemical and Biophysical Research Communications·William R EnglishGillian Murphy
Sep 15, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elizabeth D HoodVladimir R Muzykantov
Jan 24, 2013·Nature Reviews. Molecular Cell Biology·Robert G Parton, Miguel A del Pozo
Dec 19, 2013·Journal of Neurochemistry·Maya Pascual-LucasConsuelo Guerri
Jan 7, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Piotr S KowalskiJan A A M Kamps
Jan 8, 2014·Annual Review of Pharmacology and Toxicology·Melissa D HowardVladimir R Muzykantov

❮ Previous
Next ❯

Citations

Jun 30, 2018·Advanced Materials·Jacob W MyersonVladimir R Muzykantov
Aug 2, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R Yu KiselevaC F Greineder
Aug 10, 2019·Current Pathobiology Reports·Ana CartayaEdward M Bahnson
Mar 12, 2019·Communications Biology·Gabriela M MarchettiRuchi Gupta
May 23, 2020·Bioengineering & Translational Medicine·Taras LysyyGregory T Tietjen
Jan 10, 2021·Colloids and Surfaces. B, Biointerfaces·Clarinda CostaM Luísa Corvo
Aug 8, 2020·Advanced Drug Delivery Reviews·Yaping JuSarah F Hamm-Alvarez
Jun 25, 2020·Advanced Drug Delivery Reviews·Patrick M GlassmanVladimir R Muzykantov
Nov 27, 2020·International Journal of Biological Macromolecules·Arianna Carolina RosaFranco Dosio
Dec 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mihaela BadeaRodica Olar
Oct 24, 2020·American Journal of Respiratory Cell and Molecular Biology·Zicheng DengVladimir V Kalinichenko
Mar 9, 2019·Free Radical Biology & Medicine·Hong YuRonald J Korthuis
Apr 23, 2021·Trends in Pharmacological Sciences·Liudmila L MazaleuskayaGarret A FitzGerald
Mar 14, 2020·Bioconjugate Chemistry·Patrick M GlassmanColin F Greineder
Sep 20, 2021·Drug Discovery Today·Jennifer N Hennigan, Michael D Lynch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Vladimir V ShuvaevVladimir R Muzykantov
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Vladimir V ShuvaevVladimir R Muzykantov
© 2022 Meta ULC. All rights reserved